MASI · Masimo Corporation
$0.00
—
End-of-day data · updated 2026-07-25
Market cap
$9B
Enterprise value
$10B
Trailing P/E
44.4
Forward P/E
26.9
Dividend yield
—
Beta
1.10
Avg volume
1M
Employees
2K
2D change
—
5D change
—
10D change
—
30D change
—
60D change
—
MTD change
—
YTD change
—
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Technical data is temporarily unavailable for MASI.
Analyst sentiment over time — MASI
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-03-27
Latest call per bank · past 12 months
Wells Fargo
Equal-Weight$180
Bank of America
Neutral$162
Recent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-03-27 | Raymond James | Downgrade | Outperform → Market Perform | $0.00 |
| 2026-02-18 | Wells Fargo | Downgrade | Overweight → Equal-Weight | $190 → $180 |
| 2026-02-18 | BTIG | Downgrade | Buy → Neutral | $0.00 |
| 2025-12-04 | BTIG | Maintains | Buy | $198 → $200 |
| 2025-11-24 | BTIG | Reiterates | Buy | $198 |
| 2025-11-17 | Bank of America | Initiates | Neutral | $0.00 → $162 |
| 2025-11-05 | Wells Fargo | Maintains | Overweight | $190 → $187 |
| 2025-11-05 | BTIG | Reiterates | Buy | $198 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
MASI Price Chart
Loading chart for MASI…
Fundamentals
About Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
More in Medical Devices
ABT
Abbott Laboratories
$180B -16.2% YTD
SYK
Stryker Corporation
$127B -5.5% YTD
MDT
Medtronic plc.
$107B -11.9% YTD
BSX
Boston Scientific Corporation
$66B -53.6% YTD
EW
Edwards Lifesciences Corporatio
$48B -3.1% YTD
GEHC
GE HealthCare Technologies Inc.
$28B -26.1% YTD
DXCM
DexCom, Inc.
$28B 7.8% YTD
PHG
Koninklijke Philips N.V. NY Reg
$25B 0.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.